Live Analyst Rating Changes 16810 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Zachary Evershed
NB

Zachary Evershed

National Bank
Wall Street Analyst
★★★★★
#244
on 13Foresight · ranked by our own returns
69%
Success Rate
+12.5%
Average Return
9 of 13 calls profitable · -3.3% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 69% of Zachary Evershed's ratings turned a profit when each position was held for 1 year — averaging +12.5% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

9 Buy 4 Hold 0 Sell
Zachary's Stock Coverage 13 ratings · 2026-08-02
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
TSE:CAS
Cascades
 Apr 13, 2026 HOLD Strong Buy
+8.6% avg upside
5 analysts
$14.00
4.02% Upside
 +25.9% ·
TSE:AGTF
AGT Food and Ingredients Inc
 Mar 30, 2026 BUY Strong Buy
+40.8% avg upside
6 analysts
$26.00
51.42% Upside
 -9.3% ·
TSE:SIS
Savaria
 Dec 22, 2025 BUY Strong Buy
+5.2% avg upside
7 analysts
$30.00
3.01% Upside
 +27.7% ·
TSE:AD.UN
Alaris Royalty
 Nov 10, 2025 BUY Buy
+3.2% avg upside
10 analysts
$27.00
9.61% Upside
 +34.0% ·
TSE:TVK
TerraVest
 Aug 15, 2025 BUY Strong Buy
+41.8% avg upside
6 analysts
$185.00
61.93% Upside
 -10.2% ·
TSE:BYD
Boyd Group Services
 Aug 14, 2025 BUY Strong Buy
+60.5% avg upside
20 analysts
$250.00
72.44% Upside
 -31.6% ·
TSE:ADEN
ADENTRA
 Aug 11, 2025 BUY Strong Buy
+27.9% avg upside
7 analysts
$42.50
22.43% Upside
 +7.1% ·
TSE:DXT
Dexterra Group
 Aug 07, 2025 BUY Strong Buy
-39.0% avg upside
7 analysts
$14.00
10.07% Downside
 +63.0% ·
TSE:RCH
Richelieu Hardware
 Jun 26, 2025 HOLD Hold
+7.1% avg upside
2 analysts
$37.00
4.28% Upside
 +17.4% ·
TSE:DBM
Doman Building Materials Group
 Jun 26, 2025 BUY Strong Buy
-1.9% avg upside
7 analysts
$10.50
6.74% Downside
 +39.4% ·
TSE:MATR
Mattr
 Mar 18, 2025 BUY Strong Buy
+22.1% avg upside
12 analysts
$19.00
10.61% Upside
 -15.6% ·
TSE:JWEL
Jamieson Wellness Inc
 Mar 14, 2024 BUY Strong Buy
-4.1% avg upside
9 analysts
$36.00
13.02% Downside
 +11.4% ·
TSE:KPT
KP Tissue
 Mar 08, 2024 HOLD Hold
+10.9% avg upside
4 analysts
$9.00
30.46% Downside
 +3.8% ·
🔒 8 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Zachary Evershed — Frequently Asked Questions
How accurate are Zachary Evershed's stock ratings?
Based on the calls 13Foresight could measure, about 69% of Zachary's ratings were profitable over a one-year hold, with an average return of +12.5% per rating, or +81.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Zachary ranked on 13Foresight?
Zachary Evershed is currently ranked #244 with a 5-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Zachary cover?
Zachary most recently has ratings on TSE:CAS, TSE:AGTF, TSE:SIS, TSE:AD.UN, TSE:TVK, TSE:BYD, TSE:ADEN, TSE:DXT, TSE:RCH, TSE:DBM, TSE:MATR, TSE:JWEL and 1 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.